A Study to Validate a New Oral Fluid/Saliva Antibody Test for Novel H1N1v Influenza
Completed
- Conditions
- H1N1 Virus
- Registration Number
- NCT01192958
- Lead Sponsor
- Public Health England
- Brief Summary
At present influenza immunity can only be reliably confirmed by a blood test. This test is invasive for the patient. This study is intended to validate an oral fluid/saliva antibody test for the variant Swine Influenza H1N1. If such a test were available, this painless and non invasive test will improve direct clinical care to an individual as well as significantly help guide future public health management of the pandemic.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Participants of the clinical service evaluation of novel H1N1v vaccine
- First or second blood sample for the clinical service evaluation successfully collected
Exclusion Criteria
- Withdrawn from clinical service evaluation of novel H1N1v vaccine
- Second blood sample for the clinical service evaluation not collected.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method